Keep an eye on materials, energy and healthcare


Published 18-DEC-2018 10:28 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Anyone investing in the stock market right now must be asking themselves two questions. Firstly, are we likely to see a change in trend from down to up and secondly, if it is changing direction how strongly will it continue to trade up into 2019?

After closing up slightly at 5,757.90 points a fortnight ago, the market continued to trade up last week, which is an early signal that the market may be changing direction. The All Ordinaries has repeatedly found support between 5,700 and 5800 given that in the last eight weeks it has opened or closed within this price range on six occasions, which indicates that the market is resilient and the bears are not strong in numbers.

Materials was the best performing sector last week, up over 2 per cent with strong rises from RIO, BHP and FMG all up 3 to 5 per cent, which was supported by a weakening AUD and rising iron ore prices. The Energy and Information Technology sectors were also up this week around 1 per cent.

It was a different story for the Telecommunications sector (XTJ), which is down around 4 per cent. This sector continues to look worse for wear down around 18 per cent so far this year mainly on the back of Telstra, which is down around 20 per cent for the year.

On Thursday the Australian Competition and Consumer Commission flagged concerns about shrinking competition that could ultimately leave consumers worse off in the $15 billion proposed merger between TPG and Vodafone. TPG shares fell 17 per cent at the open on Thursday morning to $6.35. It recovered somewhat during the day, however it closed only slightly higher at $6.45 for the day as it struggled to find support.

Interestingly, Telstra also fell on the news from the ACCC with their share price down 5.3 per cent from the open. Investors speculated that if the merger between TPG and Vodafone fails to get through this may result in more competition for Telstra around its pricing and service offerings.

It has been a rough year for Telstra shareholders. In fact, it has been a rough 21 years since it first hit the stock market. This is because the company often disappoint the market, which is reflected in the share price. While things were initially looking up over the past few months, there is nothing exciting happening with Telstra to signal a buy right now, although it may not be too long before that changes.

Our Telecommunications sector tends to move in parallel to the US Telco sector. Over the past month it is looking more bearish, although there is likely to be some good opportunities to trade Telco stocks in 2019.

That said, Telstra still has a lot to prove and the timing is just not right at this point, although it is one to put on your watch list.

For Telstra to indicate it is bullish, we need to see an increase in momentum and for the price to rise above $3.09 in the short term. As for TPG, it is expected to continue to fall to around $6.00-$6.20.

So what do we expect in the market?

The market is turning from bearish to bullish as all the signs are there for it to turn. It may just be that the timing for the turn has been pushed out a few weeks. Given this, the Australian market will rise over the next two to four weeks and move up through 6000 points with my attention is on the Materials, Energy and Healthcare sectors.

Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in book stores and online at

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free